Regarding γδ T cells, Capietto and colleagues recently reported that adoptive transfer of human Vγ9Vδ2-expressing γδ T lymphocytes from healthy donors (HDs) together with trastuzumab reduced growth of HER2-expressing breast cancer tumors grafted into immunocompromised mice. This evidence concerns the gene ERBB2 and breast cancer.